| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2934859 | International Journal of Cardiology | 2008 | 5 Pages |
Abstract
In conclusion, the early administration of GP IIb/IIIa inhibitors, in particular of abciximab, in patients with STEMI in whom primary angioplasty is planned should not be discouraged because of the potential bleeding risk in case of emergency CABG.Â
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marco De Carlo, Daniele Maselli, Bernardo Cortese, Nicola Ciabatti, Roberto Gistri, Maurizio Levantino, Alberto Balbarini, Raffaele De Caterina, Anna Sonia Petronio,